ESPE2018 Poster Presentations Bone, Growth Plate & Mineral Metabolism P2 (24 abstracts)
Adolescent and Young Adult Program, Department of Child and Adolescent Health and Department of Community, Primary Care and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland.
Introduction: Vitamin D plays a key role in bone health of adolescents. Meanwhile, its potential extra-skeletal health benefits have resulted in the association of vitamin D deficiency with a wide range of acute and chronic diseases. As a consequence, hypovitaminosis D in adolescence is considered to have serious adverse effects and is highlighted as a global public health concern. Practical guidelines help clinicians make their preventive and therapeutic choices and improve care management.
Objective: Our purpose was to collect and synthesize available recommendations concerning vitamin D in adolescents, mainly vitamin D thresholds and vitamin D status, dietary requirements, prophylactic supplementation and treatment of deficiency.
Methods: We conducted a systematic review of the literature. We searched guidance published by different professional associations and governments from different regions of the world.
Results: We identified thirty-one documents. Most of them targeted the general population and not specifically the age group of adolescents. There is general agreement that adolescents should not have serum 25hydroxyvitamin D concentrations below 2530 nmol/L in order to avoid poor bone health. However, there is lack of consensus on the optimal concentration to aim for, levels varying between 25 nmol/L and 125 nmol/L. Adequate nutritional requirements of vitamin D are also controversial with values varying between 200 IU/d and 1,000 IU/d. The upper tolerable intake is estimated at 4,000 IU/d by all study groups. Certain associations recommend routine vitamin D supplementation in adolescents. The recommended daily doses vary between 400 IU and 2,000 IU, depending on skin pigmentation, sun exposure, consumption of vitamin D-fortified foods, body mass index and coexistence of certain medical conditions. In case of deficiency, an oral daily regimen of vitamin D, ergocalciferol/D2 or cholecalciferol/D3, is recommended for at least 4 weeks. A maintenance dose after the end of treatment is essential and is usually equivalent to the daily dietary intake recommended by the relevant study group.
Conclusion: At present, there is no consensus among the different societies and countries about vitamin D during adolescence. In clinical settings, this lack of consent makes decisions difficult or problematic under certain clinical conditions. Strong guidance is needed to establish homogenous, evidence-based recommendations.